Conmed (CNMD) Current Assets (2010 - 2026)

Conmed's Current Assets history runs 17 years deep, the most recent figure standing at $670.6 million for Q1 2026.

• Quarterly Current Assets rose 4.94% year-over-year to $670.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $670.6 million (up 4.94% YoY) and the FY2025 annual result came in at $672.9 million, up 5.13% from the prior year.
• Current Assets was $670.6 million for Q1 2026 at Conmed, roughly flat from $672.9 million in the prior quarter.
• Across five years, Current Assets topped out at $672.9 million in Q4 2025 and bottomed at $488.3 million in Q1 2022.
• A 5-year average of $619.5 million and a median of $625.6 million in 2023 frame the typical range for Current Assets.
• Annual changes were most pronounced in 2022 — Current Assets soared 30.24% — and 2025, when it rose 0.52%.
• Conmed's Current Assets stood at $581.2 million in 2022, then increased by 5.92% to $615.6 million in 2023, then increased by 3.96% to $640.0 million in 2024, then advanced by 5.13% to $672.9 million in 2025, then slipped by 0.34% to $670.6 million in 2026.
• Business Quant data shows CNMD's Current Assets at $670.6 million in Q1 2026, $672.9 million in Q4 2025, and $662.2 million in Q3 2025.